Article
Six European Countries Halt AstraZeneca COVID-19 Vaccine Use
Author(s):
The US ranks first in the world in vaccines administered.
This article was originally published in ContagionLive.
Multiple countries in the European Union (EU) have suspended use of the AstraZeneca’s COVID-19 vaccine.
Despite EU medicine regulators urging them to think twice about the decision, Denmark, Norway, Iceland, Bulgaria, Ireland and the Netherlands decided to follow through due to concerns that the vaccine was causing a rare combination of blood clots and lowered levels of blood platelets.
In Hong Kong, due to a good rollout of their inoculation program, officials have announced an expansion of the priority groups allowed for vaccination. Individuals aged 30-59, domestic workers and students aged 16 and older who are studying abroad will now be able to get a shot. The city now expects to cover around 5.5 million of its nearly 7 million population.
Lastly, due to fears of a third wave of COVID-19 hitting Europe, many governments are beginning to reinstate measures that were used earlier on in the pandemic to try and halt the spread.
On Monday, much of Italy went into lockdown that is expected to last through the Easter weekend. Likewise, France has also begun to add more restrictions like curfews after a surge in cases was seen within the Paris region.
Data Table per Our World in Data (March 15, 2021, 12 AM EST)
As travel begins to reach peak numbers amid the pandemic within the US, more airports have begun to open COVID-19 testing areas. Two testing locations opened up before security at Reagan National Airport and Dulles International Airport on Monday morning, making them the tenth and eleventh in the country, respectively.
Data Table per CDC COVID-19 Tracker (March 14, 2021, 6 AM EST)
For more information on COVID-19 vaccination research, distribution, and assessment, check out some of these recent Contagion stories:
Pfizer and BioNTech Report 97% COVID-19 Vaccine Efficacy in Israel Population
Single Dose of mRNA Vaccine May be Enough for COVID-19 Experienced People
